169 related articles for article (PubMed ID: 25109475)
1. Valsartan independent of AT₁ receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions.
Ha YM; Park EJ; Kang YJ; Park SW; Kim HJ; Chang KC
J Cell Mol Med; 2014 Oct; 18(10):2031-43. PubMed ID: 25109475
[TBL] [Abstract][Full Text] [Related]
2. Valsartan ameliorates ageing-induced aorta degeneration via angiotensin II type 1 receptor-mediated ERK activity.
Shan H; Zhang S; Li X; Yu K; Zhao X; Chen X; Jin B; Bai X
J Cell Mol Med; 2014 Jun; 18(6):1071-80. PubMed ID: 24548645
[TBL] [Abstract][Full Text] [Related]
3. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
[TBL] [Abstract][Full Text] [Related]
4. Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats.
Chan P; Wong KL; Liu IM; Tzeng TF; Yang TL; Cheng JT
J Hypertens; 2003 Apr; 21(4):761-9. PubMed ID: 12658023
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina.
Kurihara T; Ozawa Y; Nagai N; Shinoda K; Noda K; Imamura Y; Tsubota K; Okano H; Oike Y; Ishida S
Diabetes; 2008 Aug; 57(8):2191-8. PubMed ID: 18487452
[TBL] [Abstract][Full Text] [Related]
6. Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes.
Iwashita M; Sakoda H; Kushiyama A; Fujishiro M; Ohno H; Nakatsu Y; Fukushima T; Kumamoto S; Tsuchiya Y; Kikuchi T; Kurihara H; Akazawa H; Komuro I; Kamata H; Nishimura F; Asano T
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E286-96. PubMed ID: 22045314
[TBL] [Abstract][Full Text] [Related]
7. Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity.
Hasan AU; Ohmori K; Hashimoto T; Kamitori K; Yamaguchi F; Ishihara Y; Ishihara N; Noma T; Tokuda M; Kohno M
Hypertens Res; 2014 Jul; 37(7):621-8. PubMed ID: 24599011
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
Müller DN; Mervaala EM; Dechend R; Fiebeler A; Park JK; Schmidt F; Theuer J; Breu V; Mackman N; Luther T; Schneider W; Gulba D; Ganten D; Haller H; Luft FC
Am J Pathol; 2000 Jul; 157(1):111-22. PubMed ID: 10880382
[TBL] [Abstract][Full Text] [Related]
9. Valsartan blocked alcohol-induced, Toll-like receptor 2 signaling-mediated inflammation in human vascular endothelial cells.
Wang Y; Li Y; Shen Q; Li X; Lu J; Li X; Yin D; Peng Y
Alcohol Clin Exp Res; 2014 Oct; 38(10):2529-40. PubMed ID: 25346502
[TBL] [Abstract][Full Text] [Related]
10. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors.
Yong QC; Thomas CM; Seqqat R; Chandel N; Baker KM; Kumar R
Cardiovasc Diabetol; 2013 Nov; 12():169. PubMed ID: 24215514
[TBL] [Abstract][Full Text] [Related]
12. Valsartan inhibits NPC cell line CNE-2 proliferation and invasion and promotes its sensitivity to radiation.
Wang Q; Zhao W; Wu G
Eur J Cancer Prev; 2009 Nov; 18(6):510-7. PubMed ID: 19687742
[TBL] [Abstract][Full Text] [Related]
13. Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade.
Awad AS; Webb RL; Carey RM; Siragy HM
J Hypertens; 2004 Aug; 22(8):1571-7. PubMed ID: 15257181
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.
Bruder-Nascimento T; Chinnasamy P; Riascos-Bernal DF; Cau SB; Callera GE; Touyz RM; Tostes RC; Sibinga NE
J Mol Cell Cardiol; 2014 Jan; 66():18-26. PubMed ID: 24445059
[TBL] [Abstract][Full Text] [Related]
15. Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression.
Huang J; Siragy HM
Endocrinology; 2009 Dec; 150(12):5557-65. PubMed ID: 19861503
[TBL] [Abstract][Full Text] [Related]
16. Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice.
Cole BK; Keller SR; Wu R; Carter JD; Nadler JL; Nunemaker CS
Hypertension; 2010 Mar; 55(3):715-21. PubMed ID: 20100990
[TBL] [Abstract][Full Text] [Related]
17. Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARγ activation.
Chen HY; Xu Z; Chen LF; Wang W; Fang Q; Yan XW
J Cardiovasc Pharmacol; 2012 Jun; 59(6):570-5. PubMed ID: 22392065
[TBL] [Abstract][Full Text] [Related]
18. Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells.
Azuma K; Tamura K; Shigenaga A; Wakui H; Masuda S; Tsurumi-Ikeya Y; Tanaka Y; Sakai M; Matsuda M; Hashimoto T; Ishigami T; Lopez-Ilasaca M; Umemura S
Hypertension; 2007 Nov; 50(5):926-32. PubMed ID: 17875818
[TBL] [Abstract][Full Text] [Related]
19. Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors.
Abdel-Rahman EM; Abadir PM; Siragy HM
Am J Physiol Regul Integr Comp Physiol; 2008 Nov; 295(5):R1473-8. PubMed ID: 18799632
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
Motawi TK; El-Maraghy SA; Senousy MA
J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
